The Development and Severity of Infectious Uveitis

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 359

Special Issue Editors


E-Mail Website
Guest Editor
Department of Ophthalmology, University of Illinois College of Medicine, Chicago, IL 60612, USA
Interests: infectious uveitis; endophthalmitis; intravitreal antibiotics; ocular syphilis; ocular tuberculosis; diagnostic testing; epidemiology
Department of Ophthalmology, University of Illinois College of Medicine, Chicago, IL 60612, USA
Interests: infectious uveitis; endophthalmitis; intravitreal antibiotics; ocular syphilis; ocular tuberculosis; diagnostic testing; epidemiology

E-Mail Website
Guest Editor
Ocular Virology Lab, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA
Interests: virology; drug delivery; sustained release; antiviral; eye; genitalia
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Infections are a leading cause of ocular inflammation worldwide. By exogenous or endogenous transmission, a wide variety of pathogens including bacteria, viruses, fungi, and parasites can cause infectious uveitis. While certain entities such as toxoplasmosis, syphilis, and tuberculosis comprise the majority of cases of intraocular inflammation, other emerging pathogens have also been shown to cause uveitis. The development of infectious uveitis can range from rapidly progressive fulminant infection to a chronic, indolent course. Diagnosis of intraocular infections can be challenging and multiple factors may lead to significant ocular morbidity including delay in diagnosis, drug-resistant infections, and concomitant inflammation, which can destroy ocular tissues. This Special Issue seeks manuscripts on the pathogenesis, severity, diagnosis, and management of infectious uveitis with a special focus on clinical presentation and management challenges, new diagnostic testing modalities, and antimicrobial drug delivery options.

Dr. Ann Marie Lobo
Dr. Pooja Bhat
Dr. Tejabhiram Yadavalli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infectious uveitis
  • endophthalmitis
  • intravitreal antibiotics
  • ocular syphilis
  • ocular tuberculosis
  • diagnostic testing
  • epidemiology

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop